Could taking epilepsy meds three times a day stop more seizures?

NCT ID NCT07490769

Recruiting now Disease control Sponsor: Waad Alkathiri Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This Phase 3 trial tests whether taking levetiracetam three times daily (instead of the usual twice daily) leads to more seizure-free days in adults with uncontrolled epilepsy. 120 participants will take the drug three times a day for 12 months and compare their results to their own past seizure records. The study also tracks side effects like dizziness and mood changes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Levetiracetam (an anti-seizure medication)
What this could lead to: If successful, this could show that taking levetiracetam three times a day controls seizures better than the standard twice-daily schedule.
What could go wrong: This is a small, early-phase trial with only 120 participants, and it uses a self-controlled design rather than a placebo group. Side effects like dizziness or mood changes may also limit tolerability.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPILEPSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EPILEPSY

Contacts and locations

Locations

King Saud University
RECRUITING

Riyadh, Riyadh Region, 13321, Saudi Arabia

More trials for these conditions

Other studies related to the condition(s) this trial covers.